Cost–effectiveness analysis of pembrolizumab for patients with advanced esophageal cancer at PD-L1 combined positive score ≥10 - Supplementary materials

Name: Cost–effectiveness analysis of pembrolizumab for patients with advanced esophageal cancer at PD-L1 combined positive score ≥10 - Supplementary materials
Creator: Future Science Group
Published: 2022-08-31 08:51:14
License: 暂无描述

DataCite Commons2022-08-31 更新2025-04-15 收录

下载链接：

https://future-science-group.figshare.com/articles/dataset/Cost_effectiveness_analysis_of_pembrolizumab_for_patients_with_advanced_esophageal_cancer_at_PD-L1_combined_positive_score_10_-_Supplementary_materials/20747086/1

下载链接

链接失效反馈

官方服务：

资源简介：

Transition probability of progressive free status to progressive free status(pFTF), progressive free status to death(pFTD), progressive free status to progressive status(pFTP)

提供机构：

Future Science Group

创建时间：

2022-08-31